09-Jan-2013 - ALMAC GROUP LTD

Almac and TTP Labtech form alliance in fluorescence lifetime technology

Almac and TTP Labtech announced the formation of an alliance in the field of fluorescence lifetime (FLT) technology to provide screening performance.

FLT as a reading modality offers a robust, antibody-free, homogeneous assay platform which enables the user to avoid interference from fluorescent compounds within a screening library. Developed utilising experience in peptide engineering and chemical synthesis and design, Almac’s FLEXYTE™ assays harness potential of FLT to provide an efficient and economical platform for screening and profiling. The evolving assay platform offers solutions for many major therapeutic target classes including kinases, proteases, phosphatases, DUB and an increasing number of epigenetic targets.

Facts, background information, dossiers
More about ALMAC GROUP
  • News

    Almac successfully completes knowledge transfer partnership with Queens University

    Almac announces the completion of the Knowledge Transfer Partnership (KTP) with Queens University Belfast, to develop, improve and embed bioprocesses in order to facilitate the delivery of novel products for its biocatalysis business.  The project was awarded the highest grade of “Outstandi ... more

    Almac doubles drug product development capacity with a new non-GMP facility

    Almac announces the expansion of the drug product Pharmaceutical Development services with the creation of a new non-GMP formulation development facility and two new analytical laboratories at the UK headquarters in Craigavon. Whereas, the existing GMP facilities can support drug product ma ... more

    Charlie Morris appointed to Almac’s executive team

    The Almac Group’s Clinical Technologies business unit announces that Charlie Morris has joined the company as Vice President of New Products and Services.  In this role, Mr. Morris will report directly to Jim Murphy, President of Almac Clinical Technologies, and will oversee the development ... more

  • Companies


    Almac has the most comprehensive range of integrated drug development services available to the biopharmaceutical industry. Employing over 2,000 highly skilled individuals, the privately owned company is headquartered in Craigavon, Northern Ireland and has extensive facilities in the UK an ... more

More about SPT Labtech Ltd
  • News

    David Newble joins TTP Labtech as new managing director

    TTP Labtech announced the appointment of David Newble as its new managing director. Dr. Jas Sangera, founder, managing director and key driver for the company for the last 14 years, will continue his role as the company’s chairman.David Newble has a proven track record of growing life scien ... more

    TTP LabTech announces 25% revenue growth and a push on R&D

    TTP LabTech has announced a 25% increase in total revenue for the last fiscal year. Bucking the trend, TTP LabTech’s products have sustained continued growth within the last 12 months, generating revenues of £9.1 million compared with £7.3 million from the previous year. Furthermore, this i ... more